Case Series of Ventricular Tachycardia and Myocarditis From Programmed Cell-Death Protein-1 Inhibitor Treated With Infliximab

JACC Clin Electrophysiol. 2019 Aug;5(8):989-992. doi: 10.1016/j.jacep.2019.05.001. Epub 2019 Aug 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • Fatal Outcome
  • Female
  • Humans
  • Infliximab* / adverse effects
  • Infliximab* / therapeutic use
  • Kidney Neoplasms / drug therapy
  • Middle Aged
  • Myocarditis* / chemically induced
  • Myocarditis* / diagnosis
  • Myocarditis* / therapy
  • Ovarian Neoplasms / drug therapy
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Tachycardia, Ventricular* / chemically induced
  • Tachycardia, Ventricular* / diagnosis
  • Tachycardia, Ventricular* / therapy

Substances

  • Antineoplastic Agents
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Infliximab